Securities code: 688553 securities abbreviation: Sichuan Huiyu Pharmaceutical Co.Ltd(688553) Sichuan Huiyu Pharmaceutical Co.Ltd(688553)
The first extraordinary general meeting of shareholders in 2022
Conference materials
Meeting time
January 2022
Sichuan Huiyu Pharmaceutical Co.Ltd(688553)
Documents of the first extraordinary general meeting of shareholders in 2022
catalogue
Sichuan Huiyu Pharmaceutical Co.Ltd(688553) ...... Notes to the first extraordinary general meeting of shareholders in 2002 3 Sichuan Huiyu Pharmaceutical Co.Ltd(688553) ...... 5 agenda of the first extraordinary general meeting of shareholders in 2002 5 Sichuan Huiyu Pharmaceutical Co.Ltd(688553) ...... 720 proposal of the first extraordinary general meeting of shareholders in 2002 7 Sichuan Huiyu Pharmaceutical Co.Ltd(688553) ...... Proposal of the first extraordinary general meeting of shareholders in 2002 8 Sichuan Huiyu Pharmaceutical Co.Ltd(688553) ...... Proposal of the first extraordinary general meeting of shareholders in 92022 nine
Sichuan Huiyu Pharmaceutical Co.Ltd(688553)
Notes to the first extraordinary general meeting of shareholders in 2022
In order to safeguard the legitimate rights and interests of the majority of investors and ensure that shareholders exercise their rights according to law during the shareholders' meeting, in accordance with the company law, the rules for the shareholders' meeting of listed companies of the CSRC, the rules of procedure for the shareholders' meeting of the company and other relevant provisions, it is hereby formulated that the meeting shall know:
1、 The company is responsible for the agenda arrangement and affairs of the general meeting of shareholders. In order to confirm the attendance qualification of shareholders or their agents or other attendees, the meeting staff will check the identity of the attendees and ask the verified ones to cooperate.
2、 Shareholders and shareholders' agents attending the meeting shall go through the sign in formalities at the meeting site half an hour before the meeting, and show the securities account card, identity documents or copies of business license / registration certificate (stamped with official seal), power of attorney, etc. as required. A copy of the above registration materials shall be provided, and the copy of personal registration materials shall be signed by individuals, The copy of the legal representative's certificate must be stamped with the company's official seal and can attend the meeting only after verification. After the commencement of the meeting, the chairman of the meeting shall announce the number of shareholders attending the meeting and the total number of voting shares held by them. After that, the shareholders entering the meeting have no right to participate in the on-site voting.
3、 The meeting deliberated and voted on proposals in the order listed in the meeting notice.
4、 Shareholders and their agents enjoy the right to speak, question and vote according to law. Shareholders and their agents attending the general meeting of shareholders shall earnestly perform their legal obligations, shall not infringe upon the legitimate rights and interests of the company and other shareholders and their agents, and shall not disturb the normal order of the general meeting of shareholders.
5、 The shareholders and their proxies who request to speak shall speak in accordance with the agenda of the meeting and with the permission of the chairman of the meeting. When more than one shareholder and shareholder's agent request to speak at the same time, the one who raises his hand first shall speak; When the order cannot be determined, the host shall designate the speaker. The speeches or questions of shareholders and their agents shall focus on the topics of the general meeting of shareholders, be concise and concise, and the time shall not exceed 5 minutes.
6、 When shareholders and their proxies request to speak, they shall not interrupt the report of the meeting reporter or the speeches of other shareholders and their proxies. When voting at the general meeting of shareholders, shareholders and their proxies will no longer speak. If shareholders and their agents violate the above provisions, the chairman of the meeting has the right to refuse or stop them.
7、 The moderator may arrange the company's directors and senior managers to answer the questions raised by the shareholders. For questions that may disclose the company's trade secrets and / or insider information and damage the common interests of the company and shareholders, the moderator or its designated relevant personnel have the right to refuse to answer.
8、 Shareholders and their proxies attending the general meeting of shareholders shall express one of the following opinions on the proposal submitted for voting: agree, oppose or abstain. Shareholders and their proxies attending the on-site meeting must sign the names of shareholders on the voting votes. The votes that are not filled in, wrongly filled in, illegible and not cast shall be deemed as the voters' waiver of voting rights, and the voting results of their shares shall be counted as "waiver".
9、 The general meeting of shareholders adopts the combination of on-site voting and online voting, and issues the announcement of the resolution of the general meeting of shareholders in combination with the voting results of on-site voting and online voting.
10、 The general meeting of shareholders was witnessed by the practicing lawyer of the law firm hired by the company and issued a legal opinion. 11、 During the meeting, the participants shall pay attention to maintaining the order of the meeting place, shall not walk around at will, the mobile phone shall be adjusted to the silent state, and personal recording, video recording and photographing shall be refused. The meeting staff shall have the right to stop the acts that interfere with the normal order of the meeting or infringe on the legitimate rights and interests of other shareholders and report to the relevant departments for handling.
12、 The expenses incurred by shareholders and their agents attending the general meeting of shareholders shall be borne by the shareholders themselves. The company does not issue gifts to shareholders attending the general meeting of shareholders, nor is it responsible for arranging the accommodation of shareholders attending the general meeting of shareholders, so as to treat all shareholders equally.
13、 The shareholders and their agents are requested to strictly abide by the relevant national requirements on covid-19 pneumonia epidemic prevention and attend the meeting in an orderly manner.
Sichuan Huiyu Pharmaceutical Co.Ltd(688553)
Agenda of the first extraordinary general meeting of shareholders in 2022
1、 Meeting time, place and voting method 1. On site meeting time: 10:30 a.m. on Thursday, January 27, 2022 2 2. On site meeting place: conference room on the fourth floor of Sichuan Sichuan Huiyu Pharmaceutical Co.Ltd(688553) Co., Ltd., building 3, No. 333 Hanyang Road, Shizhong District, Neijiang City, Sichuan Province
3. Convener: Sichuan Huiyu Pharmaceutical Co.Ltd(688553) board of directors 4. Moderator: Chairman Ding Zhao 5. Online voting system, start and end time and voting time
Online voting system: online voting system for shareholders' meeting of Shanghai Stock Exchange
Starting and ending time of online voting: from January 27, 2022 to January 27, 2022
The online voting system of Shanghai Stock Exchange is adopted. The voting time through the trading system voting platform is the trading time period on the day of the general meeting of shareholders, i.e. 9:15-9:25, 9:30-11:30, 13:00-15:00; The voting time through the Internet voting platform is 9:15-15:00 on the day of the general meeting of shareholders. 2、 Agenda of the meeting: (I) participants sign in and receive meeting materials (II) the host announces the beginning of the meeting and reports to the general meeting the number of shareholders attending the on-site meeting and the table held by them
Number of decision-making rights, and introduce the participants and non voting participants of the on-site meeting
(III) the moderator read out the instructions to the general meeting of shareholders (IV) recommended the vote counter and the vote scrutinizer (V) to consider the proposals of the meeting item by item. Name of non cumulative voting proposal 1. Proposal on using part of the over raised funds to invest in the construction of new projects 2. Proposal on foreign investment in private placement funds and related party transactions by wholly-owned subsidiaries 3. Proposal on daily related party transactions expected in 2022
(VI) speeches and questions by shareholders and their proxies (VII) voting on various proposals by shareholders and their proxies (VIII) adjournment, vote counter The scrutineer counts the on-site voting results (IX) summarizes the online voting and on-site voting results (x) the host reads out the voting results and resolutions of the general meeting of shareholders (XI) the witness lawyer reads out the legal opinions of the general meeting of shareholders (XII) signs the meeting documents (XIII) the host announces the end of the general meeting of shareholders
Sichuan Huiyu Pharmaceutical Co.Ltd(688553)
Proposal of the first extraordinary general meeting of shareholders in 2022
Proposal I. proposal on using part of the over raised funds to invest in the construction of new projects reviewed by shareholders and shareholder agents:
The company plans to use the over raised funds of 288.61 million yuan, accounting for 63.66% of the total over raised funds of the company, to invest in the high-end green drug industry chain extension project invested and constructed by the wholly-owned subsidiary Sichuan Zeyu Pharmaceutical Co., Ltd.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) on January 12, 2022 The Sichuan Huiyu Pharmaceutical Co.Ltd(688553) announcement on investment and construction of new projects with some over raised funds (Announcement No.: 2022-003) disclosed.
The above proposal has been deliberated and adopted at the 20th meeting of the first board of directors held on January 11, 2022, and is hereby submitted to the general meeting of shareholders for deliberation.
Sichuan Huiyu Pharmaceutical Co.Ltd(688553) board of directors January 27, 2022
Sichuan Huiyu Pharmaceutical Co.Ltd(688553)
Proposal of the first extraordinary general meeting of shareholders in 2022
Proposal II. Proposal on foreign investment in private equity funds and related party transactions by wholly-owned subsidiaries
Consideration by shareholders and their agents:
In order to improve the company's capital utilization, return on investment and realize the company's strategic development. Sichuan Huiyu Pharmaceutical Technology Co., Ltd., a wholly-owned subsidiary, plans to use its own and self raised funds of RMB 50 million to subscribe for the fund products of the private placement fund of Zhuzhou Wenzhou Junzhe venture capital partnership (limited partnership) (hereinafter referred to as "Wenzhou Junzhe").
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) on January 12, 2022 Announcement on Sichuan Huiyu Pharmaceutical Co.Ltd(688553) foreign investment in private equity funds and related party transactions by wholly-owned subsidiaries (Announcement No.: 2022-004).
The above proposal has been deliberated and adopted at the 20th meeting of the first board of directors held on January 11, 2022, and is hereby submitted to the general meeting of shareholders for deliberation.
Sichuan Huiyu Pharmaceutical Co.Ltd(688553) board of directors January 27, 2022
Sichuan Huiyu Pharmaceutical Co.Ltd(688553)
Proposal of the first extraordinary general meeting of shareholders in 2022
Proposal III. proposal on daily related party transactions of the company in 2022. Deliberation by shareholders and shareholder agents:
According to the business needs of the company and the related party transactions in 2021, the daily related party transactions between the company and Fujian Nanfang Pharmaceutical Co., Ltd. in 2022 are expected to be RMB 25 million.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) on January 12, 2022 Disclosed Sichuan Huiyu Pharmaceutical Co.Ltd(688553) announcement on daily connected transactions expected in 2022 (Announcement No.: 2022-005).
The above proposal has been deliberated and adopted at the 20th meeting of the first board of directors held on January 11, 2022, and is hereby submitted to the general meeting of shareholders for deliberation.
Sichuan Huiyu Pharmaceutical Co.Ltd(688553) board of directors January 27, 2022
